Thomas Neill Selected Research

Decorin

2/2022	The Role of Decorin Proteoglycan in Mitophagy.
1/2022	Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.
11/2020	Proteoglycan-driven Autophagy: A Nutrient-independent Mechanism to Control Intracellular Catabolism.
1/2020	Catabolic degradation of endothelial VEGFA via autophagy.
2/2016	Decorin as a multivalent therapeutic agent against cancer.
12/2015	Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases.
10/2015	Decorin is an autophagy-inducible proteoglycan and is required for proper in vivo autophagy.
8/2015	Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.
7/2015	Oncosuppressive functions of decorin.
4/2014	Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Neill Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 12/2010
13	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2012
4	Carcinogenesis 11/2020 - 01/2012
3	Hypoxia (Hypoxemia) 05/2013 - 02/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020 - 05/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 12/2017
2	Inflammation (Inflammations) 01/2017 - 04/2015
2	Neoplasm Metastasis (Metastasis) 12/2015 - 04/2015
1	Disease Progression 02/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Pathologic Processes 04/2015

Drug/Important Bio-Agent (IBA)

19	DecorinIBA 02/2022 - 12/2010
10	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 12/2010
10	Phosphotransferases (Kinase)IBA 01/2019 - 12/2010
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
5	Proteoglycans (Proteoglycan)IBA 01/2019 - 12/2010
5	Small Leucine-Rich ProteoglycansIBA 07/2015 - 12/2010
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022 - 12/2012
3	ProgranulinsIBA 11/2020 - 12/2016
2	Proto-Oncogene Proteins c-metIBA 02/2022 - 11/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2020 - 12/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 05/2020 - 05/2013
2	Oxygen (Dioxygen)IBA 10/2019 - 12/2012
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2018 - 01/2017
2	CateninsIBA 12/2015 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 02/2012
1	MicroRNAs (MicroRNA)IBA 02/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	LigandsIBA 11/2020
1	Microfilament Proteins (Actin Binding Proteins)IBA 11/2020
1	Ephrin-A1 (Ephrin A1)IBA 11/2020
1	Insulin ReceptorIBA 05/2020
1	Collagen ReceptorsIBA 05/2020
1	Protein Isoforms (Isoforms)IBA 05/2020
1	Discoidin Domain Receptor 1IBA 05/2020
1	Therapeutic UsesIBA 01/2020
1	HymecromoneIBA 01/2019
1	NexusIBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	GlycosaminoglycansIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	EnzymesIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	sortilinIBA 12/2017
1	perlecanIBA 01/2017
1	LuciferasesIBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	BiglycanIBA 08/2015
1	Mitochondrial DNA (mtDNA)IBA 02/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2014
1	angiokinesIBA 05/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2013
1	Calcineurin InhibitorsIBA 12/2012
1	Biological ProductsIBA 01/2012
1	Coloring Agents (Dyes)IBA 12/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2015
1	Castration 12/2017